🇮🇳 India Miscellaneous🇮🇳 India
India May Extend Tax Breaks on Pharma Raw Materials Past June 30
The Hindu·Wednesday, 10 June 2026
The Indian government is considering extending duty exemptions on pharmaceutical inputs beyond the current June 30 deadline. India's pharma exports touched just over $31 billion in FY2026. The government is also focusing on diversifying export markets to keep that growth going.
Why It Matters
India is one of the world's largest medicine exporters. Keeping raw material costs low helps Indian drug companies stay competitive globally, which affects both jobs and medicine availability.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.